Bupa, the international healthcare company, today announces it has completed the acquisition of Acıbadem Sigorta, Turkey’s second largest health insurer.
Acıbadem Sigorta is a specialist health insurance provider with both corporate and individual customers. Headquartered in Istanbul, it has over 500 employees and covers 600,000 lives. In 2017 Acıbadem Sigorta generated gross written premiums of TRY913m.
Simeon Preston, CEO of Bupa International Markets, said: "We are delighted to announce that Bupa’s acquisition of Acıbadem Sigorta is now complete. Bupa will benefit from Acıbadem Sigorta’s local market knowledge, and their customers and employees will benefit from the strength of our expertise and experience. We look forward to welcoming Acıbadem Sigorta into the Bupa family.”
Gökhan Gürcan CEO of Acıbadem Sigorta added: “We’re delighted to join Bupa. Together we will build on Acibadem Sigorta’s successes from the last 26 years and support the continued development of the Turkish health insurance market.”
Notes to editor
For more information please contact:
Fran Chambers, Customer and Corporate Affairs Director, Bupa International Markets
E: [email protected] / T: 07815 851690
Acıbadem Sigorta
Headquartered in Istanbul, Acıbadem Sigorta is a specialist provider of health insurance services for the corporate and individual segments. From 2013 to 2017, Acıbadem Sigorta increased its GWP market share from 12% to 18% and became the number one Turkish health insurer in corporate business and number two overall. Acıbadem Sigorta is managed by an experienced executive team – each member of the senior management team has over 20 years of experience in the industry.
Acıbadem Sigorta is the largest health insurer in the Turkish Corporate PMI segment with a 27% share of GWP. In the individual PMI segment it is the third-placed player with a 9% market share.
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 31 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
